Occupational cases with allergic reaction to fragrance substances, which refer to various chemicals providing aroma characteristics, are arising with its recent usage diversification from pharmaceutical, perfume industry to aromatic remedies. However, chemicals responsible for fragrance allergy have hardly been identified because its component is complex and its sensitization is not frequent. This report will present a case of acute allergic dermatitis that is likely induced by 3-hexylthiophene, one of aromatic compounds often contained in fragrance substances. The case, who was a 27-year male researcher engaged in organic chemical synthesis for six years, was exposed to 3-hexylthiophene and its product (2-bromo-3-hexylthiophene) through an experiment in May 2004 and itching, swelling and eczema immediately developed from face to back. This case of sensitization to 3-hexylthiophene suggests that it be a possible allergen for fragrance allergy.
Background
Occupational cases of allergic dermatitis caused by aromatic compounds have been seen in the perfume industry and among aromatherapists [1, 2] . Sensitization to aromatic compounds, although infrequent [3, 4] , has been reported sporadically since the 1970s as allergies to rubber products [5] , anti-epileptic drugs [6] , fragrance substances [7, 8] , and chemicals used in organic chemistry [9] . Common features of allergy to these are dermatitis on the axillae, face, neck, wrists, and behind the ears and hand eczema [3] . However, it has been difficult to identify the responsible chemicals from aromatic compounds because of their complex contents.
In these settings, volatile odorous mixtures of aromatic compounds are generally used as essential and fragrant oils. These oils often contain 3-hexylthiophene [1, 10] , which is also an aromatic compound. Whilst 3-hexylthiophene has recently been used to produce conducting polymers, major occupational sites of exposure to 3-hexylthiophene are the perfume industry and aromatherapy [1, 2] , where the number of workers using these oils is increasing [1, 4] . We experienced a case of atopic dermatitis due to 3-hexylthiophene, which has not been identified as a cause of acute dermatitis.
Case presentation

Case story
The patient was a 27-year-old male researcher who had conducted research on organic chemical synthesis for six years. Several years ago, he developed eczema acutum on his face and neck during an experiment examining the synthesis of organic chemicals using ferrocene (CAS number 102-54-5). He consulted a dermatologist in a university hospital and was diagnosed with mild atopic dermatitis due to chemical exposure; however, the sensitizer was not identified in a multiple antigen test. He had no other history of dermatological disease. In May 2004, he conducted an experiment to examine the bromination of 3-hexylthiophene (CAS number 1693-86-3). The experiment is described in detail elsewhere [11] . He had performed the same experiment at a smaller scale approximately two weeks before this episode, but had not suffered from any dermatitis.
On the morning of 14 May 2004 (day 1), he dissolved 3-hexylthiophene (95 mmol) in 150 ml of chloroform (CAS number 67-66-3) and acetic acid (CAS number 64-19-7) in a 1:1 ratio by volume. The catalyst N-bromosuccinimide (95 mmol; CAS number 128-08-5) was added within 30 minutes with stirring. This process was conducted in a fume hood at room temperature, while the original experiment was performed at 0°C [11] . The solution was stirred for 30 minutes. After he extracted the products using a separating funnel in the afternoon, the extract was washed with KOH solution (2 mol) and diluted water, and then dried using a rotary evaporator. The extraction and evaporation of solvent were performed outside the fume hood for 30 minutes, although a stopper was used for this operation. Immediately during this process, itching and swelling spread from the periocular skin over his entire face. Throughout the experiment, he wore gloves, a laboratory coat, and goggles, and noticed no odours. In the same laboratory, another researcher conducted another organic synthesis experiment, but had no symptoms. The latter experiment was conducted inside a different fume hood that was sufficiently distant from the case to avoid exposure. By midnight, the rash and itching had spread over his entire body. There were no systemic symptoms such as vomiting, diarrhoea, dyspnoea, or wheezing.
On day 2, the chloroform was evaporated from the dry extract using a rotary evaporator. The extract was refined through a chromatography column filled with silica gel and hexane, producing 59.4 mmol (63%) of 2-bromo-3-hexylthiophene. Possible by-products of the experiment were other hexylthiophenes, such as 2-bromo-4-hexylthiophene, 3-bromo-4-hexylthiophene, 2,4-dibromo-3-hexylthiophene, 2,5-dibromo-3-hexylthiophene, 2,3-dibromo-4-hexylthiophene, and 2,4,5-tribromo-3-hexylthiophene. The volumes of these products were probably small.
The experiment was terminated on Day 3. His skin symptoms worsened further (Figures 1 and 2) . On Day 8, a dermatologist diagnosed them as atopic dermatitis. They were treated with an ointment and anti-allergic pills beginning on Day 8. The eczema disappeared around Day 14, and he did not conduct any further experiments for one month. No patch test or scratch test was administered to detect a sensitizer. Since 2007, he has conducted similar experiments using these chemicals, except 3-hexylthiophene. No further dermatitis has developed.
Discussion
Except for the extraction process on Day 1, the experiment was conducted in a fume hood with sufficient ventilation (> 0.5 m/s). For protection, the patient had worn gloves, a laboratory coat, and goggles. Nonetheless, eczema acutum developed rapidly on his neck and back immediately after he worked outside the fume hood on Day 1. It is postulated that a small amount of vapour of either the reagents used or the substances generated during the experiment [12] (Table 1) caused his acute dermatitis. The likely aetiology of the acute dermatitis in this case was atopic dermatitis or irritant contact dermatitis. Eczema may result from systemic, medication-induced, physical, or psychological causes or xerosis or infections [13] . However, these were unlikely because he did not have a history of any of these diseases.
For a definitive diagnosis, a scratch test or patch test is required, but they were not administered. We had to rely on deductive inference instead. The rapid development of eczema on his face and neck suggested either atopic dermatitis due to type 1 hypersensitivity or irritant contact dermatitis initially. The subsequent spread of the rash and itching to his entire body, where direct contact with any vapour was unlikely, indicated atopic dermatitis due to type 4 hypersensitivity as well. The rash on his skin was diagnosed as atopic dermatitis by a dermatologist. It is likely that the main aetiology was atopic dermatitis [14] , although irritant contact dermatitis[15] may have preceded it.
3-Hexylthiophene, chloroform, and acetic acid evaporate readily at room temperature [12] and he may have been exposed to any of these. After this episode, however, he frequently used chloroform, acetic acid, and Nbromosuccinimide in other organic syntheses without developing a rash. Thus, it was unlikely that these chemicals, other than 3-hexylthiophene, were responsible for the patient's acute dermatitis.
Conclusions
Occupational cases of allergic dermatitis caused by aromatic compounds have been seen in the perfume industry and among aromatherapists [1, 2] . However, it remains difficult to identify the chemicals responsible of dermatitis from the complex contents of volatile oils [3, 10, 16] . This case suggests that hypersensitivity to 3-hexylthiophene be a possible cause of allergic dermatitis induced by volatile oils.
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